Trial NCT04301011

View at ClinicalTrials.gov 
Org. Study IDs: TBio-6517-ITu-001

Last trial update was posted on 2023-11-27

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma Carcinoma, Squamous Cell Melanoma Mesothelioma Mesothelioma, Malignant Oropharyngeal Neoplasms Squamous Cell Carcinoma of Head and Neck Uterine Cervical Neoplasms

Other Conditions

Cervical Cancer Cutaneous Squamous Cell Carcinoma HPV Positive Oropharyngeal Squamous Cell Carcinoma Melanoma (Skin) Microsatellite Stable Colorectal Cancer Oropharynx Cancer Renal Cell Carcinoma Solid Tumor

Stopping Reasons

Sponsor decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID